A non-catalytic herpesviral protein reconfigures ERK-RSK signaling by targeting kinase docking systems in the host.
Alexa, A., Sok, P., Gross, F., Albert, K., Kobori, E., Poti, A.L., Gogl, G., Bento, I., Kuang, E., Taylor, S.S., Zhu, F., Ciliberto, A., Remenyi, A.(2022) Nat Commun 13: 472-472
- PubMed: 35078976 
- DOI: 10.1038/s41467-022-28109-x
- Primary Citation of Related Structures:  
7OPM, 7OPO - PubMed Abstract: 
The Kaposi's sarcoma associated herpesvirus protein ORF45 binds the extracellular signal-regulated kinase (ERK) and the p90 Ribosomal S6 kinase (RSK). ORF45 was shown to be a kinase activator in cells but a kinase inhibitor in vitro, and its effects on the ERK-RSK complex are unknown ...